Protagonist Therapeutics
PTGX
PTGX
127 hedge funds and large institutions have $1.15B invested in Protagonist Therapeutics in 2021 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 43 increasing their positions, 40 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
4% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 26
12.21% less ownership
Funds ownership: 113.41% → 101.2% (-12%)
28% less call options, than puts
Call options by funds: $810K | Put options by funds: $1.12M
Holders
127
Holding in Top 10
5
Calls
$810K
Puts
$1.12M
Top Buyers
| 1 | +$17M | |
| 2 | +$11.2M | |
| 3 | +$10.6M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$10.2M |
| 5 |
OWP
Obermeyer Wealth Partners
Aspen,
Colorado
|
+$10M |
Top Sellers
| 1 | -$14.2M | |
| 2 | -$8.14M | |
| 3 | -$4.1M | |
| 4 |
RI
RTW Investments
New York
|
-$3.7M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$3.69M |